In a multi-institutional study published today in Nature Nanotechnology, researchers from The University of Texas MD Anderson Cancer Center reported that engineered bispecific nanobodies successfully strengthened mucosal defenses in the respiratory tract, improving protection against influenza infection and reducing SARS-CoV-2 transmission in vivo.

Wen Jiang, M.D., Ph.D., associate professor of Radiation Oncology, has been researching different nanotechnologies for their potential use in delivering cancer therapies. That research has led to work with Liming Zhou, M.D., a postdoctoral student, and the late Charles Chan, Ph.D., assistant professor of surgery at Stanford Medicine.